DR. GREG A. FITZKE, MD

LINCOLN, NE

Research Active
Surgery NPI registered 21+ years 2 publications 1997 – 2020 NPI: 1255334124

Practice Location

1001 S 70TH ST STE 100
LINCOLN, NE 68510

Phone: (402) 441-4760

What does GREG FITZKE research?

Dr. Fitzke studies diabetes management specifically in children with Wolcott-Rallison syndrome, a genetic disorder known for causing early-onset diabetes and other complications. He investigates how children with this syndrome manage their blood sugar levels and the associated complications, utilizing data from patient databases. Additionally, he explores the bowel health of children with cystic fibrosis, comparing the thickness of their colon walls to those of healthy children to understand potential gastrointestinal issues that may arise from this disease.

Key findings

  • In children with Wolcott-Rallison syndrome, 70% experienced severe complications from diabetes.
  • 90% of patients with Wolcott-Rallison syndrome were using insulin pumps for diabetes management.
  • 81% of cystic fibrosis patients had colon wall thickness of 2 mm or more, a significant indicator of gastrointestinal issues.
  • The thickest colon wall measured in cystic fibrosis patients was 6.5 mm, which does not occur in healthy individuals.

Frequently asked questions

Does Dr. Fitzke study diabetes?
Yes, he specifically studies diabetes in children with Wolcott-Rallison syndrome.
What conditions does Dr. Fitzke research?
He researches Wolcott-Rallison syndrome and cystic fibrosis.
What treatments has Dr. Fitzke investigated?
He investigates treatment methods for managing diabetes, including the use of insulin pumps.
How does Dr. Fitzke's work help patients?
His findings assist healthcare providers in improving diabetes management and understanding bowel health issues in children with specific genetic conditions.
Is Dr. Fitzke's work relevant to families of children with cystic fibrosis?
Yes, his research on bowel health is crucial for families managing cystic fibrosis.

Publications in plain English

Diabetes management in Wolcott-Rallison syndrome: analysis from the German/Austrian DPV database.

2020

Orphanet journal of rare diseases

Welters A, Meissner T, Konrad K, Freiberg C, Warncke K +8 more

Plain English
This study looked at how diabetes is managed in children with Wolcott-Rallison syndrome (WRS), a genetic condition that causes early diabetes along with other health issues. Researchers analyzed data from 11 patients and found that 70% experienced severe diabetes complications, while 90% were using insulin pumps. Additionally, most patients had high blood sugar levels that did not meet the ideal target, and some tragically passed away at very young ages. Who this helps: This information is crucial for doctors treating children with WRS to improve their diabetes management and care strategies.

PubMed

Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls.

1997

Gut

Haber HP, Benda N, Fitzke G, Lang A, Langenberg M +2 more

Plain English
This study looked at the thickness of the colon walls in children with cystic fibrosis compared to healthy children. Researchers found that 81% of cystic fibrosis patients had colon wall thickness of 2 mm or more, while healthy controls never reached this measurement, with the thickest wall in cystic fibrosis patients measuring 6.5 mm. This matters because it highlights the presence of significant bowel changes in cystic fibrosis that could lead to serious gastrointestinal issues, even when patients are receiving treatment. Who this helps: This helps patients with cystic fibrosis and their healthcare providers.

PubMed

Frequent Co-Authors

Alena Welters Thomas Meissner Katja Konrad Clemens Freiberg Katharina Warncke Sylvia Judmaier Olga Kordonouri Michael Wurm Matthias Papsch Silke Christina Schmidt

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.